The Spectrum of Pulmonary Toxicity in Pancreatic Cancer Patients Receiving Gemcitabine Combination Chemotherapy

Gemcitabine is widely utilized in the treatment of pancreatic, ovarian, and non small cell lung cancers. Gemcitabine is associated with a wide spectrum of lung toxicities, ranging from dyspnea 25% of patients to severe pulmonary toxicity in up to 5% of patients. There is a dearth of information spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Jalal, Shokouh-Amiri, Mohammad, Chan, Juliana, Chowdhery, Rozina, Danthurthy, Samaya, Venepalli, Neeta K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639581/
https://www.ncbi.nlm.nih.gov/pubmed/31341464
http://dx.doi.org/10.1159/000500242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639581/
https://www.ncbi.nlm.nih.gov/pubmed/31341464
http://dx.doi.org/10.1159/000500242

Ejemplares similares